Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine

British Journal of Pharmacology

Volumn 128, Issue 7, 1999, Pages 1361-1369

  Liptay, Susanne ^a   Bachem, Max ^a   Häcker, Georg ^b   Adler, Guido ^a   Debatin, Klaus M ^a   Schmid, Roland M ^a  

^a UNIVERSITY OF ULM   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

5ASA; Chronic inflammatory diseases; Inflammatory bowel disease; NF B; Sulfapyridine; Sulfasalazine; T lymphocytes

Indexed keywords

DNA FRAGMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; MESALAZINE; PROTEIN INHIBITOR; SALAZOSULFAPYRIDINE; SULFAPYRIDINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032705303     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702937     Document Type: Article

References (51)

1. ANDERSON, G.P. (1996). Resolution of chronic inflammation by therapeutic induction of apoptosis. TIPS, 17, 438-442.
2. ARDITE, E., PANÉS, J., MIRANDA, M., SALAS, A., ELIZALDE, J.I., SANS, M., ARCE, Y., BORDAS, J.M., FERNÁNDEZ-CHECA, J.C. & PIQUÉ, J.M. (1998). Effects of steroid treatment on activation of nuclear factor κB in patients with inflammatory bowel disease. Br. J. Pharmacol., 124, 431-433.
3. AZAD KHAN, A.K., PIRIS, J. & TRUELOVE, S.C. (1977). An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet, 2, 892-895.
4. BIRD, H.A. (1995). Sulphasalazine, sulphapyridine or 5-aminosalicylic acid which is the active moiety in rheumatoid arthritis? Br. J. Rheumatol., 34 (suppl. 2), 16-19.
5. BOIRIVANT, M., MARINT, M., DI FELICE, G., PRONIO, A.M., MOTESANI, C., TERSIGNI, R. & STROBER, W. (1999). Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology. 116, 557-565.
6. CARBONARI, M., CIBATI, M., CHERCHI, M., SBARIGIA, D., PESCE, A.M., DELL'ANNA, L., MODICA, A. & FIORILLI, M. (1994). Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood, 83, 1268-1277.
7. COHEN, J.J. & DUKE, R.C. (1992). Apoptotis and programmed cell death in immunity. Annu. Rev. Immunol., 10, 267-293.
8. DAS, K.M., EASTWOOD, M.A., MCMANUS, J.P.A. & SIRCUS, W. (1973). The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients. Gut, 14, 631-641.
9. EGAN, L.J., KEAN, D.J.M., MAYS, D.C., BELL, M., HUNTOON, C., PIKE, M.G., SANDBORN, W.J. & LIPSKY, J.J. (1999). Mesalamine regulates nuclear factor kappa B (NF-κB) activity in intestinal epithelial cells by a novel mechanism: inhibition of inducible phosphorylation of RcIA (p65). Gastroenterology, 116, G3064.
10. FIOCCHI, C. (1998). Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology, 115, 182-205.
11. FRANTZ, B. & O'NEILL, E.A. (1995). The effect of sodium salicylate and aspirin on NF-κB. Science. 279, 2017-2018.
12. FRIESEN, C., HERR, I., KRAMMER, P.H. & DEBATIN, K.M. (1996). Involvement of the CD95 (APO-I/Fas) receptor/ligand system in drug-induced apoptosisin leukemia cells. Nat. Med., 2, 574-577.
13. FUJIWARA, M., MITSUI, K. & YAMAMOTO, I. (1990). Inhibition of proliferative responses and interleukin 2 production by salazosulfapyridine and its metabolites. Jpn. J. Pharmacol., 54, 121-132.
14. GACINELLA, T.S. & WALSH, R.E. (1992). Sulfasalazine: multiplicity of action. Dig. Dis. Sci., 37, 801-812.
15. GHOSH, S., MAY, M.J. & KOPP, E.B. (1998). NF-κB and Rel proteins. Evolutionary conserved mediators of immune responses. Annu. Rev. Immunol., 16, 225-260.
16. HASLETT, C. (1992). Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin. Sci. (Lond), 83, 639-648.
17. INA, K., BINION, D.G., WEST, G.A., DOBREA, G.M. & FIOCCHI, C. (1995). Secretion of soluble factors and phagocytosis by intestinal fibroblasts regulate T-cell apoptosis. Gastroenterology, 108, A841.
18. JUBIN, C., HASKILL, S., MAYER, L., PANJA, A. & SARTOR, R.B. (1997). Evidence for altered regulation of IκBα degradation in human colonic epithelial cells. J. Immunol., 158, 226-234.
19. KAISER, G.C., VAN, F. & POLK, D.B. (1999). Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor κB activation in mouse colonocytes. Gastroenterology, 116, 602-609.
20. KLOTZ, U., MAIER, K., FISCHER, C. & HEINKEL, K. (1980). Therapeutic efficacy of sulfasalsizine and its metabolites in patients with ulcerative colitis and Crohn's disease. N. Engl. J. Med., 303, 1499-1502.
21. KOPP, E. & GHOSH, S. (1994). Inhibition of NF-κB by sodium salicylate and aspirin. Science, 265, 956-959.
22. KOOPMAN, G., REUTELINGSPERGER, C.P.M., KUIJTEN, G.A.M., KEEHNEN, R.M.J., PALS, S.T. & VAN OERS, M.H.J. (1994). Annexin V for flow cytometric detection of phosphatidyscrine expression on B cells undergoing apoptosis. Blood, 84, 1415-1420.
23. KRAMMER, P.H., DHEIN, J., WALCZAK, H., BEHRMANN, I., MARIANI, S., MATIBA, B., FATH, M., DANIEL, P.T., KNIPPING, P., WESTENDORP, M.O., STRICKER, K., BÄUMLER, C., HELLBARDT, S., GERMER, M., PETER, M.E. & DEBATIN, K.M. (1994). The role of APO-I-mediated apoptosis in the immune system. Immunnl. Rev., 142, 175-191.
24. LIPTAY, S., SCHMID, R.M., NABEL, E.G. & NABEL, G.J. (1994). Transcriptional regulation of NF-κB2: evidence for κB-mediated positive and negative autoregulation. Mol. Cell Biol., 14, 7695-7703.
25. MACDONALD, H.R. & LEES, R.K. (1990). Programmed death of autoreactive thymocytes. Nature, 343, 642-644.
26. MCDONNELL, T.J., DEANE, N., PLATT, F.M., NUNEZ, G., JAEGER, U., MCKEARN, J.P. & KORSMEYER, S.J. (1989). Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicuiar lymphoproliferation. Cell, 57, 79-88.
27. MOUNTZ, J.D., WU, J., CHENG, J. & ZHOU, T. (1994). Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum., 37, 1415-1420.
28. MUNN, D.H., BEALL, A.C., SONG, D., WRENN, R.W. & THROCKMORTON, D.C. (1995). Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon γ. J. Exp. Med., 181, 127-136.
29. NEURATH, M.E., BECKER, C. & BARBULESCU, K. (1998). Role of NF-κB in immune and inflammatory response in the gut. Gut, 43, 856-860.
30. NEURATH, M.E., PETTERSSON, S., MEYER ZUM BÜSCHENEELD, K.H. & STROBER, W. (1996). Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat. Med., 2, 998-1004.
31. NICOLETTI, I., MIGLIORATI, G., PAGLIACCI, M.C., GRIGNANI, F. & RICCARDI, C. (1991), A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139, 271-279.
32. NISITANI, S., TSUBATA, T., MURAKAMI, M., OKAMOTO, M. & HONJO, T. (1993). The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J. Exp. Med., 178, 1247-1254.
33. OSWALD, F., LIPTAY, S., ADLER, G. & SCHMID, R.M. (1998). NF-κB2 is a putative target gene of activated notch-1 via RBP-Jκ. Mol. Cell Biol., 18, 2077-2088.
34. PANG, G., TOUCH, L., BATEY, R., CLANCY, R. & CRIPPS, A. (1994). GM-CSF., IL-1α, IL-1β, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated by lipopolysaccharide, IL-1α and TNF-α. Clin. Exp. Immunol., 96, 437-443.
35. PEPPERCORN, M.A. & GOLDMAN, P. (1973). Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology, 64, 240-245.
36. RIS, P., ANTHONSIEN, P., WULFF, H.R., FOLKENBORG, O., BONNEVIE, O. & BINDER, V. (1973). The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment: a double-blind trial on patients asymptomatic for one year. Scand. J. Gastroenterol., 8, 71-74.
37. ROGLER, G., BRAND, K., VOGL, D., PAGE, S., HOFMEISTER, R., ANDUS, T., KNUECHEL, R., BAEUERLE, P.A., SCHÖLMERICH, J. & GROSS, V. (1998). Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology, 115, 357-369.
38. SALMON, M., SCHEEL-TOELLNER, D., HUISSOON, A.P., PILLING, D., SHAMSADEEN, N., DUPUY D'ANGEAC, A., HYDE, H., BACON, P.A., EMERY, P. & AKBAR, A.N. (1997). Inhibition of T cell apoptosis in the rheumatoid synovium, J. Clin. Invest., 99, 439-446.
39. SAVILL, J.S., WYLLIE, A.H., HENSON, J.E., WALPORT, M.L., HENSON, P.M. & HASLETT, C. (1989). Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest., 83, 865-875.
40. SCHMID, R.M., PERKINS, N.D., DUCKETT, C.S., ANDREWS, P.C. & NABEL, G.J. (1991). Cloning of a NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature (London), 352, 733-736.
41. SCHREIBER, S., NICOLAUS, S. & HAMPE, J. (1998). Activation of nuclear factor κB in inflammatory bowel disease. Gut, 42, 477-484.
42. SHELDON, P.J., WEBB, C. & GRINDULIS, K.A. (1988). Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes-clues to its clinical action? Br. J. Rheumatol., 27, 344-349.
43. STRASSER, A., HARRIS, A.W., HUANG, D.C., KRAMMER, P.H. & CORY, S. (1995). Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J., 14, 6136-6147.
44. SUTHERLAND, L.R., MAY, G.R. & SHAFFER, E.A. (1993). Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann. Int. Med., 118, 540-549.
45. TAGGART, A.J., NEUMANN, V.C., HILL, J., ASTBURY, C., LE GALLEZ, P. & DIXON, J.S. (1986). 5-aminosalicylic acid or sulphapyridine, which is the active moiety of sulphasalazine in rheumatoid arthritis? Drugs, 32 (suppl. 1), 27-34.
46. THOMPSON, C.B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
47. WAHL, C., LIPTAY, S., ADLER, G. & SCHMID, R.M, (1998). Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest., 101, 1163-1174.
48. WANG, C.Y., MAYO, M.W., KORNELUK, R.G., GOEDDEL, D.V. & BALDWIN, JR., A.S. (1998). NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science, 281, 1680-1683.
49. WYLLIE, A.H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-556.
50. WYLLIE, A.H. (1998). Apoptosis. An endonuclease at last. Nature, 391, 20-21.
51. ZHANG, C., AO, Z., SETH, A. & SCHLOSSMAN, S.F. (1996). A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J. Immunol., 157, 3980-3987.